Back to results
US 2025/0144029 A1Published application
Novel compositions
AssigneeIntra-Cellular Therapies, Inc.
InventorPeng LI
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to amorphous solid dispersions comprising (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)-cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one and an excipient, as well as related methods of making and using such dispersions.
Claims20
An amorphous solid dispersion comprising (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)-cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one (Compound 1) in free base or pharmaceutically acceptable salt form and an excipient.
Dependencies are inferred from the claim text.